Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2829-2834

  Sauve, Colette ^a   Azoulay Dupuis, Esther ^a   Moine, Pierre ^b   Darras Joly, Clémence ^a   Rieux, Véronique ^a   Carbon, Claude ^a   Bédos, Jean Pierre ^a  

^a BICHAT HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; PENICILLIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; BACTERICIDAL ACTIVITY; DOSE RESPONSE; DRUG CLEARANCE; DRUG EFFICACY; FEMALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029848118     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2829     Document Type: Article

References (46)

1. Allen, K. D. 1991. Penicillin-resistant pneumococci. J. Hosp. Infect. 17:3-13.
2. Andes, D., A. Urban, and W. A. Craig. 1995. In-vivo activity of amoxicillin (AMOX) and amoxicillin/clavulanate (AMOX/CLAV) against penicillin-resistant pneumococci, abstr. A82, p. 16. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Angehrn, P., P. J. Probst, R. Reiner, and R. L. Then. 1980. Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies. Antimicrob. Agents Chemother. 18:913-921.
4. Appelbaum, P. C. 1987. Worldwide development of antibiotic resistance in pneumococci. Eur. J. Clin. Microbiol. 6:367-377.
5. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
6. Azoulay-Dupuis, E., J. P. Bédos, E. Vallée, D. J. Hardy, R. N. Swanson, and J. J. Pocidalo. 1991. Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease. J. Infect. Dis. 163:319-324.
7. Bédos, J. P., O. Rolin, D. H. Bouanchaud, and J. J. Pocidalo. 1991. Relation entre virulence et résistance aux antibiotiques des pneumocoques. Apport des données expérimentales sur un modèle animal. Pathol. Biol. 39:984-990.
8. Bergan, T. 1987. Pharmacokinetic properties of the cephalosporins. Drugs 34(Suppl. 2):89-104.
9. Beskid, G., J. G. Christenson, R. Cleeland, W. DeLorenzo, and P. W. Trown. 1981. In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin. Antimicrob. Agents Chemother. 20:159-167.
10. Boswell, T. C., K. J. Nye, and E. G. Smith. 1994. Penicillin and penicillin-cephalosporin-resistant pneumococcal septicemia. J. Antimicrob. Chemother. 34:844-845.
11. Briles, D. E., M. J. Crain, B. M. Gray, C. Forman, and J. Yother. 1992. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect. Immun. 60:111-116.
12. Brogden, R. N., and A. Ward. 1988. Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration. Drugs 35:604-645.
13. Christ, W. 1991. Pharmacological properties of cephalosporins. Infection 19(Suppl. 5):S244-S251.
14. Cleeland, R., and E. Squires. 1984. Antimicrobial activity of ceftriaxone: a review. Am. J. Med. 77:3-11.
15. Drusano, G.L. 1988. Role of pharmacokinetics in the outcome of infections. Antimicrob. Agents Chemother. 32:289-297.
16. Fang, G. D., M. Fine, J. Orloff, D. Arisumi, V. L. Yu, W. Kapoor, J. T. Grayston, S. P. Wang, R. Kohler, R. R. Muder, Y. C. Yee, J. D. Rihs, and R. M. Vickers. 1990. New and emerging etiologies for community-acquired pneumonia with implication for therapy: a prospective multicenter study of 359 cases. Medicine (Baltimore) 69:307-316.
17. Figueiredo, A. M. S., J. D. Connor, A. Severin, M. V. Vaz Pato, and A. Tomasz. 1992. A pneumococcal clinical isolate with high-level resistance to ccfotaxime and ceftriaxone. Antimicrob. Agents Chemother. 36:886-889.
18. Friedland, I. R., and G. H. McCracken. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
19. Frimodt-Moller, N., M. W. Bentzon, and V. F. Thomsen. 1986. Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters and in vivo effect for 14 cephalosporins. J. Infect. Dis. 154:511-517.
20. Frimodt-Moller, M., M. Weis Bentzon, and V. Frolund Thomsen. 1987. Experimental pneumococcus infection in mice: comparative in vitro and in vivo effect of cefuroxime, cefotaxime and ceftriaxone. Ada Pathol. Microbiol. Immunol. Scand. Sect. B 95:261-267.
21. Greenblatt, D. J., and J. Koch-Weser. 1975. Clinical pharmacokinetics. N. Engl. J. Med. 297:702-705.
22. Gutmann, L., S. Vincent, D. Billot-Klein, J. F. Acar, E. Mrèna, and R. Williamson. 1986. Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia colt by some β-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam). Antimicrob. Agents Chemother. 30:906-912.
23. Hakenbeck, R., H. Ellerbrok, T. Briese, S. Handwerger, and A. Tomasz. 1986. Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying the β-lactam binding site. Antimicrob. Agents Chemother. 30:553-558.
24. Hansman, D., and M. M. Bullen. 1967. A resistant pneumococcus. Lancet ii:264-265.
25. John, C. C. 1994. Treatment failure with the use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and a review. Clin. Infect. Dis. 18:188-193.
26. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
27. Lopez, R., C. Ronda, and E. Garcia. 1990. Autolysins are directly involved in the bactericidal effect caused by penicillin in wild type and in tolerant pneumococci. FEMS Microbiol. Lett. 66:317-322.
28. Magnusson, V., H. Erlendsdottir, K. G. Kristinsson, and S. Gudmonsson. 1995. Comparative efficacy of penicillin (P) and ceftriaxone (C) against penicillin resistant pneumococci (PRP) in a mouse pneumonia model, abstr. A89, p. 17. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
29. Marrie, T. J., H. Durant, and L. Yates. 1989. Community-acquired pneumonia requiring hospilalization: 5-year prospective study. Rev. Infect. Dis. 11:586-599.
30. McNamara, P. J., V. Trueb, and K. Stoeckel. 1988. Protein binding of ceftriaxone in extravascular fluids. J. Pharm. Sci. 77:401-404.
31. Moine, P., E. Vallée, E. Azoulay-Dupuis, P. Bourget, J.-P. Bédos, J. Bauchet, and J.-J. Pocidalo. 1994. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 38:1953-1958.
32. Munoz, R., C. G. Dowson, M. Daniels, T. J. Coffey, C. Martin, R. Hakenbeck, and B. G. Spratt. 1992. Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol. Microbiol. 6:2461-2465.
33. Munoz, R., J. M. Musser, M. Crain, D. E. Briles, A. Marton, A. J. Parkinson, U. Sorensen, and A. Tomasz. 1992. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and mullifocus enzyme analysis. Clin. Infect. Dis. 15:112-118.
34. Nath, S. K., G. A. Foster, L. A. Mandell, and C. Rotstein. 1994. Antimicrobial activity of ceftriaxone versus cefotaxime: negative effect of serum albumin binding of ceftriaxone. J. Antimicrob. Chemother. 33:1239-1243.
35. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A. National Committee for Clinical Laboratory Standards, Villanova, Pa.
36. Örtqvist, A., J. Hedlund, E. Grillner, E. Jalonem, I. Kallings, M. Leinonen, and M. Kalin. 1990. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur. Respir. J. 3:1105-1113.
37. Pallares, R., J. Linares, M. Vadillo, C. Cabellos, F. Manresa, P. F. Viladrich, R. Martin, and F. Gudiol. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-480.
38. Pankuch, G. A., M. A. Visalli, M. R Jacobs, and P. C. Appelbaum. 1995. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 39:1499-1504.
39. Patel, I. H., and S. A. Kaplan. 1984. Pharmacokinetic profile of ceftriaxone in man. Am. J. Med. 77:17-25.
40. Scaglione, F., M. Raichi, and F. Fraschini. 1990. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentration of cefotaxime and ceftriaxone in serum and pleural exudate. J. Antimicrob. Chemother. 26(Suppl. A):1-10.
41. Smith, A. M., and K. P. Klugman. 1995. Alterations in penicillin-binding protein 2B from penicillin-resistant wild-type strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39:859-867.
42. Tomasz, A. 1979. The mechanism of the irreversible antimicrobial effects of penicillins: how the β-lactam antibiotics kill and lyse bacteria. Annu. Rev. Microbiol. 33:113-137.
43. Williamson, R., and A. Tomasz. 1986. Inhibition of cell wall synthesis and acylation of the penicillin-binding proteins during prolonged exposure of growing Streptococcus pneumoniae to benzylpenicillin. Eur. J. Biochem. 151: 475-483.
44. Wright, R. B., S. D. Makover, and E. Telep. 1981. Ro 13-9904: affinity for penicillin binding proteins and effect on the cell wall synthesis. J. Antibiot. 34:590-595.
45. Yuk, J. H., C. H. Nightingale, and R. Quintilani. 1987. Clinical pharmacokinetics of ceftriaxone. Clin. Pharmacokinet. 17:223-225.
46. Zighelboim, S., and A. Tomasz. 1980. Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 17:434-442.